Expanded Access Program (EAP) for Galinpepimut-S (GPS) in Patients Diagnosed With AML or MDS
Clinical trial NCT05593185 · AVAILABLE
Trial details
- NCT number
- NCT05593185
- Sponsor
- Sellas Life Sciences Group
- Status
- AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.